Industry Trends Currently in the U.S. opthalmic device market, competition is limited from manufacturers that are either new or trying to expand into the U.S. market. Many ophthalmic device manufacturers have recently entered the market. Some of these companies are based in Italy, Japan and China, and severely undercut the prices in order to gain market
The full report suite on the U.S. market for interventional ophthalmic devices includes disease rates, ophthalmic lasers, intraocular lenses (IOLs), phacoemulsification consoles, ophthalmic viscosurgical devices (OVDs) and glaucoma shunts. Currently the U.S. market for interventional ophthalmic devices is being limited by high prices. High prices for the capital equipment in this market are passed on to the consumer as much of the interventional market is based upon elective surgeries. While many are willing to pay for premiums to undergo corrective surgery others will seek out alternative solutions or decide to live with their vision issues.
In 2016, more integration was seen in the overall market for diagnostic and interventional ophthalmic devices. In the diagnostic space, practitioners are enjoying better, more flexible diagnostic capabilities with ophthalmic data management systems; these systems unify discrete pieces of diagnostic equipment. A similar technology, procedure planning software, unifies different surgical equipment for more precise and reliable cataract surgery. This software is bringing the diagnostic and interventional sides of the market closer together, with diagnostic information being imported for use during the surgical process. Integration is also changing the competitive landscape. Topcon and Carl Zeiss Meditec, players traditionally focused on diagnostics, are now gaining footholds in the market for surgical products.